Clinical Trial

Delayed IntraCranial Hemorrhage in Oral AntiCoagulant Treated Patients With Mild Traumatic Brain Injury

Study acronym: dICH-OAC
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
As a low quality, weak recommendation, it is part of the Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults, that patient with a GCS of 14-15 and anticoagulation therapy and a normal CT should be admitted for observation for at least 24 hours. No data are available on the adverse events related to the observational 24-hour admission. The aim was to evaluate the risk of post-CT hemorrhage as well as the risk of complications to an admission (e.g. deleria, thrombosis due to pause of antithrombotic medications.
Trial Details
NCT Number NCT07195760
Lead Sponsor Bispebjerg Hospital
Conditions Head Trauma, Head Injury, Delirium, Thrombosis
Enrollment 600 participants
Start Date 2023-02-10
Primary Completion 2024-01-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-29